This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Horizon Pharma acquires worldwide rights to BI's interferon gamma-1b
20 May 2016
Horizon Pharma PLC received worldwide rights to Boehringer Ingelheim GmbH's interferon gamma-1b product (trade names Imuki, Imukine, Immukin, Immukine and Actimmune; Horizon already owns rights to the product as Actimmune in US, Canada and Japan). Under the agreement the two parties will also enter into a global supply agreement.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?